Clinical trial
Sentinel Node in Ovarian Cancer: SONAR-2
NCT02540551 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sentinel Node in Ovarian Cancer: SONAR-2
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- January 1, 2016
- Completion date
- July 1, 2019
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian neoplasms, sentinel node